arenavirus
caus
chronic
infect
rodent
worldwid
distribut
human
infect
mucos
exposur
aerosol
direct
contact
abrad
skin
infecti
materi
deriv
infect
rodent
sever
arenavirus
caus
hemorrhag
fever
hf
diseas
human
pose
great
public
health
concern
within
viru
endem
region
hand
prototyp
arenaviru
lcmv
superb
workhors
investig
virushost
interact
includ
mechan
viru
control
clearanc
host
immun
defens
well
viral
counteract
measur
lead
chronic
infect
associ
diseas
oldston
zinkernagel
review
focu
recent
develop
arenaviru
revers
genet
implic
better
understand
arenaviru
molecular
cell
biolog
well
mechan
underli
arenavirushost
interact
associ
diseas
develop
novel
antivir
drug
vaccin
strategi
combat
pathogen
arenavirus
old
world
ow
lassa
viru
lasv
sever
new
world
nw
arenavirus
caus
hf
diseas
human
thu
lasv
estim
infect
sever
hundr
thousand
individu
yearli
endem
region
west
africa
result
high
number
lassa
fever
lf
case
associ
high
morbid
signific
mortal
likewis
nw
arenaviru
junin
viru
junv
caus
argentin
hf
sever
ill
hemorrhag
neurolog
manifest
case
fatal
wherea
nw
machupo
macv
guaranito
gtov
arenavirus
emerg
caus
agent
hf
bolivia
venezuela
respect
peter
notabl
increas
travel
endem
region
led
import
lf
nonendem
metropolitan
area
around
globe
isaacson
moreov
compel
evid
indic
global
distribut
prototyp
arenaviru
lcmv
neglect
human
pathogen
clinic
signific
especi
case
congenit
infect
lead
hydrocephalu
mental
retard
chorioretin
barton
et
al
addit
lcmv
pose
special
threat
immunocompromis
individu
illustr
recent
case
transplantassoci
infect
lcmv
fatal
outcom
usa
fischer
et
al
australia
palacio
et
al
studi
prototyp
arenaviru
lcmv
led
major
advanc
virolog
immunolog
appli
univers
microbi
infect
viral
infect
human
includ
virusinduc
immunopatholog
diseas
mhc
restrict
mechan
viru
induc
immunosuppress
oldston
zinkernagel
outcom
lcmv
infect
natur
host
mous
vari
dramat
depend
strain
age
immunocompet
genet
background
host
well
rout
infect
strain
dose
infect
viru
oldston
zinkernagel
provid
investig
uniqu
model
system
investig
paramet
critic
influenc
mani
aspect
virushost
interact
includ
heterogen
phenotyp
manifest
often
associ
infect
viru
arenavirus
envelop
virus
biseg
neg
strand
ns
rna
genom
life
cycl
restrict
cell
cytoplasm
virion
pleomorph
often
spheric
cover
surfac
glycoprotein
spike
larg
l
ca
kb
small
ca
kb
genom
rna
speci
use
ambisens
code
strategi
direct
synthesi
two
polypeptid
opposit
orient
separ
noncod
intergen
region
igr
predict
fold
stabl
hairpin
structur
fig
rna
encod
viral
glycoprotein
precursor
gpc
ca
kda
nucleoprotein
np
ca
kda
wherea
l
rna
encod
viral
rna
depend
rna
polymeras
rdrp
l
polymeras
ca
kda
small
ca
kda
ring
finger
protein
z
function
counterpart
matrix
protein
found
mani
envelop
ns
rna
virus
arenavirus
exhibit
high
degre
sequenc
conserv
genom
nt
ident
ns
rna
virus
arenaviru
genom
termini
exhibit
termin
complementar
l
genom
segment
predict
form
panhandl
structur
sever
arenavirus
addit
nontempl
g
residu
detect
end
genom
rna
signific
differ
sequenc
predict
fold
structur
l
igr
among
isol
strain
arenaviru
speci
well
l
igr
sequenc
highli
conserv
np
abund
viral
polypeptid
infect
cell
virion
main
structur
element
viral
rnp
play
essenti
role
viral
rna
synthesi
recent
evid
indic
np
exhibit
also
type
interferon
ifni
counteract
activ
martinezsobrido
et
al
antiifn
activ
map
cterminu
np
recent
determin
crystal
structur
lasv
np
resolut
identifi
distinct
nand
ctermin
domain
qi
et
al
ntermin
domain
potenti
capbind
activ
could
provid
hostderiv
primer
initi
transcript
viru
polymeras
qi
et
al
contrast
ctermin
domain
fold
mimic
deddh
famili
exoribonucleas
like
one
associ
sar
corona
viru
protein
eckerl
et
al
function
studi
confirm
exoribonucleas
activ
lasv
np
propos
critic
anti
fig
arenaviru
genom
organ
virion
structur
arenavirus
envelop
virus
biseg
neg
strand
rna
genom
genom
segment
use
ambisens
code
strategi
direct
synthesi
two
viral
polypeptid
ca
kb
segment
encod
viral
nucleoprotein
np
glycoprotein
precursor
gpc
gpc
posttransl
process
l
ca
kb
segment
encod
viru
rna
depend
rna
polymeras
l
small
ring
finger
protein
z
function
arenaviru
counterpart
matrix
protein
found
mani
envelop
neg
strand
rna
virus
ifn
activ
np
dispens
role
np
replic
transcript
viral
genom
qi
et
al
assert
howev
difficult
reconcil
lack
antiifn
activ
associ
np
tacv
martinezsobrido
et
al
find
lcmv
mutant
np
lack
exoribonucleas
larg
decreas
fit
replic
ifndefici
vero
cell
martinezsobrido
et
al
viral
glycoprotein
precursor
gpc
posttransl
proteolyt
process
cellular
proteas
yield
two
matur
virion
glycoprotein
kda
kda
beyer
et
al
lenz
et
al
pinschew
et
al
gpc
contain
signal
peptid
ssp
express
stabl
polypeptid
infect
cell
remain
associ
gp
complex
gpcx
ssp
implic
differ
aspect
traffick
function
viral
envelop
glycoprotein
saunder
et
al
york
nunberg
york
et
al
mediat
viru
interact
host
cell
surfac
receptor
locat
top
spike
away
membran
held
place
ionic
interact
nterminu
transmembran
arenaviru
ring
finger
protein
z
structur
compon
virion
homologu
among
known
ns
rna
virus
lcmvinfect
cell
z
shown
interact
sever
cellular
protein
includ
promyelocyt
leukemia
pml
protein
eukaryot
translat
initi
factor
propos
contribut
noncytolyt
natur
lcmv
infect
repress
capdepend
translat
respect
borden
et
al
borden
et
al
campbel
dwyer
et
al
djavani
et
al
volpon
et
al
z
shown
arenaviru
counterpart
protein
found
mani
ns
envelop
rna
virus
play
critic
role
assembl
cell
releas
matur
infecti
virion
strecker
et
al
urata
et
al
arenaviru
l
protein
characterist
sequenc
motif
conserv
among
rdrp
l
protein
neg
strand
ns
rna
virus
poch
et
al
detail
sequenc
analysi
secondari
structur
predict
done
lasv
l
polymeras
identifi
sever
region
strong
alphahel
content
put
coiledcoil
domain
nterminu
vieth
et
al
subsequ
bioinformat
analysi
togeth
biochem
mgbase
function
studi
shown
lasv
l
protein
like
organ
three
distinct
structur
domain
specif
amino
acid
posit
lasv
l
split
nand
cpart
abl
function
transcompl
brunott
et
al
notabl
recent
electron
microscopi
character
function
macv
l
protein
reveal
core
ringdomain
decor
appendag
may
reflect
modular
organ
arenaviru
polymeras
kranzusch
et
al
consist
broad
host
rang
cell
type
tropism
highli
conserv
wide
express
cell
surfac
protein
alphadystroglycan
adg
identifi
main
receptor
lcmv
lasv
sever
arenavirus
cao
et
al
kunz
et
al
howev
mani
arenavirus
appear
use
altern
receptor
kunz
et
al
human
transferrin
receptor
identifi
cellular
receptor
use
entri
nw
hf
arenavirus
junv
macv
radoshitzki
et
al
upon
receptor
bind
arenaviru
virion
intern
uncoat
vesicl
releas
cytoplasm
phdepend
membran
fusion
step
mediat
eschli
et
al
gallah
et
al
fusion
viral
cellular
membran
releas
viral
rnp
cytoplasm
ensu
onset
viral
rna
synthesi
lcmv
mrna
nontempl
nt
cap
structur
like
obtain
cellular
mrna
via
capsnatch
mechan
whose
detail
remain
determin
recent
describ
endonucleas
activ
associ
arenaviru
l
polymeras
could
play
critic
role
process
morin
et
al
transcript
termin
subgenom
nonpolyadenyl
viral
mrna
map
multipl
site
within
distal
side
igr
meyer
southern
tortorici
et
al
suggest
igr
act
bona
fide
transcript
termin
signal
viru
polymeras
np
l
code
region
transcrib
genom
complementari
mrna
wherea
gpc
z
code
region
translat
directli
genom
rna
rather
genom
sens
mrna
transcrib
use
templat
correspond
antigenom
rna
speci
also
function
replic
intermedi
fig
assembl
cell
releas
infecti
arenaviru
progeni
requir
z
gpc
well
correct
process
cellular
site
proteas
gpc
kunz
et
al
strecker
et
al
urata
et
al
gener
infecti
rna
viru
clone
cdna
refer
revers
genet
first
report
year
ago
bacteriophag
qb
taniguchi
et
al
shortli
similar
approach
report
gener
polioviru
racaniello
baltimor
contrast
positivestrand
rna
virus
like
bacteriophag
qb
deprotein
genom
antigenom
rna
neg
strand
ns
rna
virus
like
lcmv
function
mrna
infecti
reflect
fact
templat
polymeras
ns
rna
virus
exclus
nucleocapsid
consist
genom
rna
tightli
encapsid
np
associ
viru
polymeras
protein
form
ribonucleoprotein
rnp
complex
thu
gener
biolog
activ
synthet
ns
virus
cdna
requir
tran
complement
viral
protein
involv
viru
replic
transcript
consider
hinder
applic
recombin
dna
technolog
genet
analysi
virus
howev
follow
pioneer
work
pales
group
luytj
et
al
signific
progress
made
area
ns
rna
virus
short
model
genom
aka
minigenom
mg
could
encapsid
express
plasmidencod
protein
moreov
becom
possibl
rescu
infecti
viru
entir
clone
cdna
member
famili
ns
rna
virus
kawaoka
use
revers
genet
approach
revolution
analysi
cisact
sequenc
transact
protein
requir
viru
replic
transcript
matur
bud
addit
possibl
gener
predetermin
specif
mutat
within
viru
genom
analyz
phenotyp
express
vivo
context
viru
natur
infect
contribut
significantli
elucid
molecular
mechan
underli
virushost
interact
cellular
molecular
level
provid
investig
novel
power
approach
investig
viral
pathogenesi
addit
develop
also
pave
way
engin
virus
vaccin
gene
therapi
purpos
subbarao
katz
von
messl
cattaneo
first
arenaviru
mg
rescu
system
develop
lcmv
lee
et
al
subsequ
mg
system
develop
lasv
hass
et
al
nw
arenavirus
picv
tacv
lopez
et
al
junv
albarino
et
al
result
deriv
mgbase
assay
identifi
np
l
minim
viral
transact
factor
requir
effici
rna
synthesi
mediat
viru
polymeras
hass
et
al
lee
et
al
lopez
et
al
lcmv
genet
biochem
evid
indic
oligomer
l
requir
activ
arenaviru
polymeras
sanchez
de
la
torr
consist
find
biochem
mgbase
function
studi
shown
lasv
l
protein
contain
nand
ctermini
site
mediat
interact
brunott
et
al
use
mgbase
assay
facilit
mutationfunct
studi
involv
conserv
acid
basic
amino
acid
residu
within
nand
ctermini
lasv
l
protein
uncov
sever
residu
within
nterminu
l
play
critic
role
synthesi
viral
mrna
rna
replic
hass
et
al
lelk
et
al
recent
public
resolut
crystal
structur
function
character
ntermin
residu
lcmv
l
protein
uncov
endonucleas
function
domain
similar
one
found
nterminu
influenza
viru
pa
protein
morin
et
al
mgbase
assay
shown
endonucleas
activ
critic
arenaviru
transcript
morin
et
al
mutationfunct
analysi
genom
use
lcmv
lasv
mgbase
assay
indic
activ
arenaviru
genom
promot
requir
sequenc
specif
within
highli
conserv
nt
arenaviru
genom
integr
predict
panhandl
structur
form
via
sequenc
complementar
viral
genom
rna
hass
et
al
studi
reveal
arenaviru
rna
replic
transcript
regul
coordin
manner
likewis
mgbase
assay
provid
direct
experiment
confirm
igr
bona
fide
transcript
termin
signal
pinschew
et
al
intracellular
level
np
determin
balanc
viru
rna
replic
transcript
pinschew
perez
de
la
torr
find
conceptu
similar
report
paramyxoviru
rsv
fearn
et
al
z
requir
intracellular
transcript
replic
lcmv
mg
rather
z
exhibit
dose
depend
inhibitori
effect
transcript
replic
lcmv
mg
de
la
torr
cornu
et
al
inhibitori
effect
z
also
report
tacv
lopez
et
al
lasv
hass
et
al
envelop
virus
matrix
protein
involv
organ
virion
compon
prior
assembl
interestingli
arenavirus
obviou
counterpart
howev
z
shown
main
drive
forc
arenaviru
bud
strecker
et
al
urata
et
al
process
mediat
z
late
l
domain
motif
ptap
pppi
similar
known
control
bud
sever
virus
includ
hiv
ebola
viru
via
interact
specif
host
cell
protein
freed
consist
observ
z
exhibit
featur
characterist
bona
fide
bud
protein
abil
bud
cell
substitut
effici
l
domain
target
z
plasma
membran
locat
arenaviru
bud
strictli
requir
myristoyl
perez
et
al
strecker
et
al
result
deriv
cryoelectron
microscopi
arenaviru
particl
neuman
et
al
also
consist
role
z
function
protein
gener
infecti
viru
clone
cdna
report
lcmv
flatz
et
al
arenaviru
rna
replic
gene
express
viru
rnp
deliv
cytoplasm
infect
cell
polymeras
associ
viru
rnp
initi
transcript
genom
promot
locat
genom
primari
transcript
result
synthesi
np
l
mrna
l
respect
segment
subsequ
viru
polymeras
adopt
replicas
mode
move
across
igr
gener
copi
fulllength
antigenom
rna
agrna
agrna
serv
templat
synthesi
gp
ag
z
agl
mrna
agrna
speci
serv
also
templat
amplif
correspond
genom
rna
speci
et
al
abil
gener
recombin
arenavirus
predetermin
specif
mutat
analyz
phenotyp
express
context
natur
cours
infect
open
new
opportun
investig
arenavirushost
interact
influenc
variabl
infect
outcom
rang
viru
control
clearanc
host
defens
longterm
chronic
infect
associ
subclin
diseas
sever
acut
diseas
includ
hf
gener
first
recombin
arenaviru
via
revers
genet
approach
consist
replac
lcmv
gp
gene
one
vsv
g
pinschew
et
al
viru
call
rlcmvvsvg
gener
transfect
cell
plasmid
express
recombin
lcmv
rna
segment
vsv
g
substitut
lcmv
gpc
follow
infect
wt
lcmv
helper
viru
supernat
infect
cell
contain
mix
wt
lcmv
rlcmvvsvg
select
rlcmvvsvg
done
via
passag
cell
lcmv
wt
could
produc
infecti
progeni
approach
limit
gener
rlcmv
segment
requir
timeconsum
select
process
limit
overcom
rescu
infecti
lcmv
progeni
entir
clone
cdna
use
either
rna
polymeras
rp
sanchez
de
la
torr
poli
rp
flatz
et
al
system
launch
intracellular
synthesi
l
genom
antigenom
rna
speci
subsequ
replic
transcrib
viru
polymeras
complex
reconstitut
intracellularli
via
plasmidsuppli
l
np
fig
system
exhibit
similar
effici
viru
rescu
two
system
display
phenotyp
properti
cultur
cell
vivo
success
rescu
lcmv
clone
cdna
subsequ
extend
strain
lcmv
chen
et
al
nw
arenavirus
pichind
viru
picv
junin
viru
junv
albarino
et
al
intriguingli
rescu
picv
junv
use
system
requir
plasmidsuppli
viral
np
l
protein
albarino
et
al
lan
et
al
liang
et
al
indic
rna
synthesi
produc
viral
antigenom
rna
speci
substrat
encapsid
replic
mrna
serv
templat
produc
level
np
l
suffici
high
facilit
viru
rescu
phenomenon
report
sever
negativesens
rna
virus
includ
bunyavirus
blakqori
weber
lowen
et
al
filovirus
groseth
et
al
bornavirus
schneider
et
al
moreov
orthobunyaviru
la
cross
viru
arenaviru
picv
use
plasmid
suppli
viral
transact
factor
document
diminish
effici
system
blakqori
weber
liang
et
al
revers
genet
approach
similar
use
rescu
infecti
lcmv
picv
junv
clone
cdna
applic
arenavirus
system
offer
advantag
requir
transfect
plasmid
express
viral
genom
rna
howev
also
provid
either
via
transfect
use
cell
line
stabli
express
nontempl
g
found
arenaviru
genom
rna
speci
raju
et
al
pose
problem
truncat
promot
direct
rna
synthesi
start
exhibit
good
level
transcript
activ
sousa
mukherje
activ
genom
promot
present
l
genom
rna
found
dramat
affect
mutat
nt
hass
et
al
gener
authent
viral
genom
termini
use
facilit
incorpor
hdv
ribozym
downstream
termin
sequenc
sanchez
de
la
torr
variabl
ribozym
cleavag
effici
could
neg
affect
rescu
effici
transcript
trigger
ifni
respons
via
rigi
habjan
et
al
could
compromis
rescu
recombin
virus
enhanc
suscept
infi
rna
pol
local
nucleu
cell
direct
synthesi
larg
ribosom
rna
precursor
process
rrna
comai
pol
ibas
system
first
use
influenza
viru
whose
replic
occur
nucleu
infect
cell
neumann
kawaoka
subsequ
use
rescu
varieti
ns
rna
virus
includ
bunyavirus
filovirus
arenavirus
flatz
et
al
groseth
et
al
habjan
et
al
ogawa
et
al
limit
poli
system
speciesspecif
activ
promot
comai
neumann
kawaoka
would
prevent
use
given
poli
construct
everi
cell
line
interest
hand
transcript
termin
rna
poli
occur
precis
poli
termin
signal
elimin
need
add
ribozym
end
viral
rna
pol
termin
besid
pro
con
poli
system
proven
similar
effici
rescu
arenavirus
sanchez
de
la
torr
negativesens
rna
virus
habjan
et
al
anoth
import
aspect
consid
success
arenaviru
rescu
need
confirm
sequenc
l
genom
rna
cisact
regulatori
sequenc
play
critic
role
control
rna
synthesi
viru
polymeras
minim
chang
within
would
like
prevent
viru
rescu
obtain
correct
sequenc
l
igr
sequenc
function
clone
l
polymeras
addit
key
factor
attempt
rescu
given
arenaviru
first
time
abil
gener
recombin
arenavirus
predetermin
specif
mutat
analyz
phenotyp
express
context
natur
cours
infect
open
new
opportun
investig
arenavirushost
interact
influenc
variabl
infect
outcom
rang
viru
control
clearanc
host
defens
longterm
chronic
infect
associ
subclin
diseas
sever
acut
diseas
includ
hf
thu
use
rlcmvvsvg
uncov
arenaviru
gp
viral
achil
heel
provid
foundat
novel
strategi
develop
safe
effect
liveattenu
arenaviru
vaccin
pinschew
et
al
pinschew
et
al
likewis
rlcmvvsvg
instrument
facilit
studi
aim
understand
regul
cell
function
within
infect
brain
well
virus
induc
organspecif
immun
diseas
absenc
molecular
mimicri
without
disrupt
self
toler
engin
rlcm
virus
use
studi
lasv
cell
entri
pathway
role
np
inhibit
induct
ifni
lcmv
martinezsobrido
et
al
likewis
studi
aim
examin
critic
role
play
process
arenaviru
gpc
viru
life
cycl
aid
use
recombin
virus
cleavag
site
within
gpc
replac
canon
furin
cleavag
site
albarino
et
al
rojek
et
al
urata
et
al
rescu
attenu
virul
form
picv
liang
et
al
docil
aggress
strain
lcmv
chen
et
al
allow
identif
specif
genet
determin
viru
virul
despit
facil
gener
recombin
arenavirus
abil
rescu
arenavirus
express
addit
gene
interest
pose
unexpect
difficulti
approach
success
employ
ns
rna
virus
includ
use
intern
ribosom
entri
site
ire
picornaviru
selfcleav
proteas
work
appli
lcmv
problem
overcom
gener
triseg
rlcmv
contain
segment
two
segment
alter
replac
one
two
viral
orf
gpc
np
gene
interest
goi
rational
behind
approach
physic
separ
gp
np
two
differ
segment
would
repres
strong
select
pressur
select
maintain
viru
capabl
packag
segment
varieti
rescu
express
one
two
addit
goi
depend
goi
express
protein
function
size
gene
show
littl
attenu
cultur
cell
exhibit
longterm
genet
stabil
reflect
unalt
express
level
serial
viru
passag
goi
incorpor
segment
use
express
appropri
report
gene
facilit
develop
chemic
screen
identifi
antivir
drug
well
sirnabas
genet
screen
identifi
host
cell
gene
contribut
differ
step
arenaviru
life
cycl
contrast
use
studi
virushost
interact
mice
encount
limit
due
observ
even
wt
growth
properti
cultur
cell
exhibit
attenu
phenotyp
mous
due
reason
remain
determin
har
arenaviru
revers
genet
develop
novel
strategi
combat
human
pathogen
arenavirus
vitro
vivo
studi
document
prophylact
therapeut
valu
nucleosid
analogu
ribavirin
rib
sever
arenavirus
damont
coto
importantli
rib
reduc
morbid
mortal
human
associ
lasv
infect
experiment
macv
junv
infect
given
earli
cours
clinic
diseas
damont
coto
mechan
rib
exert
antiarenavir
action
remain
poorli
understood
like
involv
target
differ
step
viru
life
cycl
parker
two
import
limit
use
rib
therapi
need
intraven
administr
optim
efficaci
signific
side
effect
includ
anemia
congenit
disord
sever
inhibitor
imp
dehydrogenas
sadenosylhomocystein
sah
hydrolas
varieti
sulfat
polysaccharid
phenotiazin
compound
brassinosteroid
myrist
acid
report
antiarenavir
activ
damont
coto
howev
compound
display
modest
rather
nonspecif
effect
associ
signific
toxic
therefor
press
need
novel
effect
antiarenavir
drug
regard
recent
highthroughput
screen
ht
use
virusinduc
cytopath
effect
cpe
base
assay
identifi
potent
small
molecul
inhibitor
tacv
sever
nw
arenavirus
bolken
et
al
likewis
cellbas
ht
base
use
pseudotyp
virion
particl
bear
gp
highli
pathogen
arenavirus
identifi
sever
small
molecul
inhibitor
viru
cell
entri
mediat
lasv
gp
find
illustr
screen
complex
chemic
librari
use
appropri
assay
repres
power
tool
identifi
candid
antivir
drug
highli
specif
activ
progress
arenaviru
revers
genet
allow
investig
dissect
step
viru
life
cycl
uncov
novel
target
develop
screen
identifi
drug
direct
specif
step
arenaviru
life
cycl
target
biosynthet
process
rna
replic
gene
transcript
direct
arenaviru
polymeras
complex
result
mutationfunct
studi
identifi
core
arenaviru
genom
promot
uncov
sequenc
specif
structur
critic
promot
activ
disrupt
interact
arenaviru
genom
promot
viru
polymeras
complex
would
interfer
essenti
biosynthet
process
viral
transcript
replic
expect
strong
deleteri
impact
viru
viabil
henc
small
molecul
interfer
specif
interact
could
efficaci
antivir
agent
effector
small
molecul
target
rna
may
interfer
rna
function
number
mechan
alter
function
threedimension
structur
rna
molecul
interact
protein
affect
also
interfac
inhibitor
may
directli
prevent
format
compet
rnaprotein
complex
studi
small
molecul
rna
effector
primarili
focus
aminoglycosid
hermann
hermann
westhof
wilson
li
antibiot
activ
associ
aminoglycosid
target
bacteri
ribosom
rna
wellknown
success
case
potenti
aminoglycosid
antivir
molecul
act
rna
illustr
abil
disrupt
select
revrr
wang
et
al
tattar
wang
et
al
interact
similar
approach
applic
inhibit
interact
arenaviru
promot
polymeras
complex
genom
core
promot
highli
conserv
among
known
arenavirus
recent
studi
defin
motif
posit
promot
play
key
role
l
polymeras
bind
kranzusch
et
al
find
predict
feasibl
identifi
aminoglycosidebas
molecul
antivir
activ
activ
differ
human
pathogen
arenavirus
mutationfunct
studi
lcmv
lasv
l
polymeras
use
mgbase
system
combin
biochem
assay
provid
evid
requir
interact
polymeras
activ
find
uncov
possibl
use
small
molecul
disrupt
interact
novel
strategi
inhibit
arenaviru
multipl
target
mediat
process
arenaviru
gpc
correct
process
arenaviru
gpc
cellular
site
proteas
strictli
requir
product
infecti
progeni
celltocel
viru
propag
therebi
intraand
interhost
viru
propag
kunz
et
al
intriguingli
studi
lcmv
junv
infect
cell
defici
indic
appear
viral
variant
capabl
grow
independ
process
gpc
appear
highli
unlik
find
strongli
support
idea
inhibitor
process
gpc
would
repres
promis
antiarenavir
drug
candid
rojek
et
al
encod
membran
bound
transcriptionfactor
proteas
site
gene
endoplasm
reticulum
er
earli
golgi
membraneanchor
serin
proteas
sakai
et
al
seidah
et
al
despit
broad
consensu
sequenc
exhibit
exquisit
substrat
specif
involv
proteolyt
process
defin
set
cellular
protein
key
role
regul
lipid
metabol
cholesterol
biosynthesi
rais
signific
interest
develop
specif
inhibitor
activ
sever
peptid
nonpeptidebas
inhibitor
document
lack
cell
permeabl
would
pose
sever
limit
use
antivir
drug
recent
decanoyl
chloromethylketon
cmk
derivat
peptid
contain
rrll
recognit
sequenc
shown
act
potent
suicid
inhibitor
catalyt
activ
drug
caus
irrevers
inhibit
catalyt
activ
host
cell
pathogen
deriv
target
might
result
unaccept
level
cellular
toxic
recent
small
molecul
report
potent
inhibitor
vitro
cellbas
assay
hawkin
et
al
hay
et
al
addit
shown
inhibit
effici
process
arenaviru
gpc
correl
drug
abil
interfer
propag
lcmv
lasv
cultur
cell
urata
et
al
arenaviru
z
protein
featur
characterist
bona
fide
bud
protein
strecker
et
al
urata
et
al
mani
character
viral
bud
protein
bud
activ
requir
interact
via
l
domain
specif
host
cellular
factor
includ
member
escrt
machineri
within
endosomalmvb
pathway
cell
regard
member
escrti
complex
identifi
host
cellular
protein
requir
zmediat
bud
accordingli
sirnamedi
knockdown
found
interfer
zmediat
bud
use
recombin
arenavirus
express
appropri
tag
version
z
facilit
studi
aim
identif
character
zhost
cell
protein
interact
involv
arenaviru
bud
context
viru
natur
cours
infect
knowledg
studi
may
uncov
novel
target
facilit
develop
screen
process
indentifi
small
molecul
capabl
disrupt
interact
therebi
interf
viru
propag
escrt
machineri
particip
varieti
process
requir
normal
cell
physiolog
carlton
morita
et
al
therefor
longterm
disrupt
normal
function
escrt
compon
like
result
unaccept
level
toxic
howev
arenaviru
induc
hf
acut
diseas
process
plausibl
short
term
inhibit
escrt
member
combat
acut
hf
arenavir
diseas
may
caus
limit
toxic
junv
live
attenu
candid
strain
deriv
mous
brain
passag
prototyp
xj
strain
junv
found
attenu
guinea
pig
preclin
studi
support
safeti
immunogen
protect
efficaci
candid
guinea
pig
rhesu
macaqu
mckee
et
al
moreov
studi
involv
agricultur
worker
junv
endem
area
shown
candid
effect
safe
vaccin
human
enria
barrera
oro
maiztegui
et
al
candid
licens
use
exclus
argentina
despit
success
limit
associ
candid
vaccin
key
concern
relat
lack
inform
genet
composit
candid
vaccin
limit
knowledg
regard
viral
genet
determin
junv
attenu
rna
virus
includ
candid
replic
perpetu
quasispeci
therefor
everi
amplif
step
increas
vaccin
product
may
result
appear
enrich
within
viru
popul
genotyp
within
potenti
exhibit
increas
virul
genet
marker
associ
candid
attenu
clearli
establish
emerg
potenti
pathogen
variant
within
candid
popul
difficult
assess
potenti
genet
instabl
candid
illustr
observ
candid
isol
obtain
blood
mononuclear
cell
vaccin
rhesu
monkey
show
fold
rang
virul
isol
exhibit
fold
higher
virul
compar
parent
candid
enria
barrera
oro
revers
genet
approach
could
facilit
develop
safer
vaccin
ahf
hf
arenavir
diseas
facilit
gener
molecular
clone
genet
welldefin
liveattenu
vaccin
strain
abil
induc
strong
protect
immun
emonet
et
al
first
use
revers
genet
approach
arenaviru
vaccin
develop
involv
gener
rlcmv
vsv
g
substitut
lcmv
gpc
rlcmv
highli
attenu
abl
induc
strong
protect
immun
find
led
examin
potenti
lcmv
viral
vector
system
immun
nonlcmv
antigen
interest
studi
show
lcmv
gpc
could
replac
protein
antigen
interest
correspond
rlcmv
grown
cell
express
gpc
abl
induc
good
immun
respons
foreign
protein
immun
mice
remain
free
diseas
symptom
flatz
et
al
howev
potenti
problem
associ
preexist
immun
lcmv
human
popul
may
limit
use
system
triseg
rlcmv
abl
stabli
express
high
level
nonlcmv
gene
interest
found
exhibit
attenu
vivo
exhibit
suffici
level
replic
induc
strong
protect
immun
subsequ
lcmv
lethal
challeng
similar
strategi
could
implement
increas
safeti
candid
among
hf
arenavirus
lasv
pose
main
concern
due
vast
endem
region
size
popul
risk
geograph
socioeconom
condit
intrins
lasv
endem
region
would
pose
signific
difficulti
individu
risk
readi
access
medic
care
includ
antivir
drug
treat
symptom
lasv
induc
diseas
therefor
vaccin
popul
risk
would
like
provid
effect
strategi
howev
vaccin
approach
lf
similar
one
use
ahf
current
unfeas
attenu
strain
lasv
establish
nevertheless
varieti
approach
pursu
aim
develop
lasv
vaccin
includ
dna
immun
approach
rodriguezcarreno
et
al
differ
vectorbas
vaccin
recombin
vaccinia
virus
express
lasv
np
gp
shown
provid
cellmedi
immun
lasv
guinea
pig
nonhuman
primat
fisherhoch
et
al
howev
approach
would
face
problem
risk
use
vaccinia
viru
base
vector
popul
high
hiv
preval
alphavirusbas
vector
use
induc
protect
immun
lasv
guinea
pig
pushko
et
al
recent
recombin
vsv
lasv
gp
substitut
vsv
g
shown
provid
protect
lethal
challeng
lasv
geisbert
et
al
likewis
alphaviru
venezuelan
equin
enceph
viru
lee
et
al
yellow
fever
vaccin
bredenbeek
et
al
shown
promis
result
whether
recombin
vaccin
provid
longterm
protect
remain
determin
issu
highli
relev
case
lf
due
cumul
lifetim
risk
exposur
lf
vaccin
within
west
africa
human
popul
induct
heterolog
immun
use
close
relat
less
pathogen
viru
also
explor
develop
lasv
vaccin
thu
reassort
call
mopeia
ow
arenaviru
consid
nonpathogen
human
lasv
shown
promis
result
carrion
et
al
detail
safeti
efficaci
studi
complet
altern
approach
develop
lf
vaccin
would
use
revers
genet
gener
biolog
contain
version
lasv
similar
way
describ
ebola
viru
halfmann
et
al
influenza
martinezsobrido
garciasastr
recent
work
lcmv
provid
strong
support
feasibl
approach
flatz
et
al
gener
safe
effect
lasv
vaccin
likewis
use
liveattenu
triseg
candid
express
relev
lasv
tcell
epitop
could
use
induc
protect
immun
junv
lasv
develop
revers
genet
system
sever
arenavirus
open
new
research
avenu
studi
basic
aspect
biolog
viru
famili
well
identif
viral
determin
mechan
sever
arenavirus
caus
hf
diseas
human
moreov
year
prototyp
arenaviru
lcmv
proven
superb
model
system
studi
virushost
interact
associ
diseas
abil
manipul
lcmv
genom
gener
rlcmv
predetermin
mutat
would
allow
investig
gain
detail
understand
role
play
differ
viral
gene
virushost
interact
result
differ
phenotyp
outcom
rang
acut
fatal
mening
immunosuppress
chronic
infect
although
clinic
silent
associ
neurobehavior
abnorm
hand
use
arenaviru
mg
cellbas
assay
singlecycl
infecti
arenavirus
offer
number
benefit
discoveri
character
antivir
drug
arenavirus
assay
allow
investig
examin
effect
antivir
drug
context
live
cell
facilit
rapid
identif
antivir
compound
obviou
undesir
cytotox
addit
assay
involv
product
life
viru
overcom
difficulti
pose
need
facil
handl
hf
arenavirus
like
lasv
junv
likewis
implement
sirnabas
screen
context
cellbas
mg
assay
facilit
identif
host
cell
protein
play
key
role
arenaviru
rna
replic
gene
express
therebi
open
potenti
discov
novel
target
could
use
develop
effect
antiarenavir
drug
